People's Republic of China

Coyote Bioscience

Coyote Bioscience (Beijing) is a, innovative Chinese high-tech company that has been engaged in molecular diagnostics for over 10 years, in particular fast nucleic acid detection technology for pathogenic microorganisms. So far, Coyote has applied for 83 domestic and international patents. As an international high-tech enterprise and a work base for academicians and experts, Coyote focuses on point-of-care testing (POCT) and research and development of its novel genetic molecular diagnostic platform.

Visit the Coyote Bioscience website

About Us



Privacy Policy & Terms of Service

© 2022 World Economic Forum

Join the Forum